Hongtao Liu1, Zhongxiao Wang2, Shujie Yu1, Jian Xu3. 1. Section of Endocrinology and Diabetes, Department of Medicine, Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. 2. Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. 3. Section of Endocrinology and Diabetes, Department of Medicine, Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA jian-xu@ouhsc.edu.
Abstract
AIMS: Hypoxia induces vascular inflammation by a mechanism not fully understood. Emerging evidence implicates O-GlcNAc transferase (OGT) in inflammation. This study explored the role of OGT in hypoxia-induced vascular endothelial inflammatory response. METHODS AND RESULTS: Hypoxia was either induced (1% O2 chamber) or mimicked by exposure to hypoxia-mimetic agents in cultured endothelial cells. Hypoxia increased hypoxia-inducible factor (HIF-1α) and inflammatory response (gene and protein expression of interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1, and E-selectin) but, surprisingly, reduced OGT protein (not mRNA) levels. Hypoxia-mimetic CoCl2 failed to reduce OGT when proteasome inhibitors were present, suggesting proteasome involvement. Indeed, CoCl2 enhanced 26S proteasome functionality evidenced by diminished reporter (Ub(G76V)-GFP) proteins in proteasome reporter cells, likely due to increased chymotrypsin-like activities. Mechanistically, β-TrCP1 mediated OGT degradation, since siRNA ablation of this E3 ubiquitin ligase stabilized OGT. Administration of the oxidative stress inhibitors reversed both proteasome activation and OGT degradation. Furthermore, up-regulation of OGT by stabilization, overexpression, or activation mitigated CoCl2-elicited inflammatory response. These observations were recapitulated in a mouse (C57BL/6J) model mimicking hypoxia, in which lung tissues presented higher levels of HIF-1α, proteasome activity, and inflammatory response, but lower levels of OGT (n = 5/group, hypoxia vs. normoxia, P < 0.05). However, administration of an activator of OGT (glucosamine: 1 mg/g/day, vehicle: saline, ip, 5 days) abolished the up-regulation of proteasome activity and inflammatory response (n = 5/group, the treated vs. untreated hypoxia groups, P < 0.05). CONCLUSIONS: 26S proteasome-mediated OGT reduction contributed to hypoxia-induced vascular endothelial inflammatory response. Modulation of OGT may represent a new approach to treat diseases characterized by hypoxic inflammation. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Hypoxia induces vascular inflammation by a mechanism not fully understood. Emerging evidence implicates O-GlcNAc transferase (OGT) in inflammation. This study explored the role of OGT in hypoxia-induced vascular endothelial inflammatory response. METHODS AND RESULTS: Hypoxia was either induced (1% O2 chamber) or mimicked by exposure to hypoxia-mimetic agents in cultured endothelial cells. Hypoxia increased hypoxia-inducible factor (HIF-1α) and inflammatory response (gene and protein expression of interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1, and E-selectin) but, surprisingly, reduced OGT protein (not mRNA) levels. Hypoxia-mimetic CoCl2 failed to reduce OGT when proteasome inhibitors were present, suggesting proteasome involvement. Indeed, CoCl2 enhanced 26S proteasome functionality evidenced by diminished reporter (Ub(G76V)-GFP) proteins in proteasome reporter cells, likely due to increased chymotrypsin-like activities. Mechanistically, β-TrCP1 mediated OGT degradation, since siRNA ablation of this E3 ubiquitin ligase stabilized OGT. Administration of the oxidative stress inhibitors reversed both proteasome activation and OGT degradation. Furthermore, up-regulation of OGT by stabilization, overexpression, or activation mitigated CoCl2-elicited inflammatory response. These observations were recapitulated in a mouse (C57BL/6J) model mimicking hypoxia, in which lung tissues presented higher levels of HIF-1α, proteasome activity, and inflammatory response, but lower levels of OGT (n = 5/group, hypoxia vs. normoxia, P < 0.05). However, administration of an activator of OGT (glucosamine: 1 mg/g/day, vehicle: saline, ip, 5 days) abolished the up-regulation of proteasome activity and inflammatory response (n = 5/group, the treated vs. untreated hypoxia groups, P < 0.05). CONCLUSIONS: 26S proteasome-mediated OGT reduction contributed to hypoxia-induced vascular endothelial inflammatory response. Modulation of OGT may represent a new approach to treat diseases characterized by hypoxic inflammation. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison Journal: Immunol Res Date: 2005 Impact factor: 2.829
Authors: Jitesh D Kawedia; Fan Yang; Maureen A Sartor; David Gozal; Maria Czyzyk-Krzeska; Anil G Menon Journal: PLoS One Date: 2013-03-01 Impact factor: 3.240
Authors: Anderson A Butler; Richard G Sanchez; Timothy J Jarome; William M Webb; Farah D Lubin Journal: Learn Mem Date: 2019-08-15 Impact factor: 2.460
Authors: Josiane Fernandes Silva; Vania C Olivon; Fabiola Leslie A C Mestriner; Camila Ziliotto Zanotto; Raphael Gomes Ferreira; Nathanne Santos Ferreira; Carlos Alberto Aguiar Silva; João Paulo Mesquita Luiz; Juliano Vilela Alves; Rubens Fazan; Fernando Queiróz Cunha; Jose Carlos Alves-Filho; Rita C Tostes Journal: Front Physiol Date: 2020-01-21 Impact factor: 4.566
Authors: Tamás Nagy; Emese Kátai; Viktória Fisi; Tamás Tibor Takács; Antal Stréda; István Wittmann; Attila Miseta Journal: Front Immunol Date: 2018-05-03 Impact factor: 7.561
Authors: Akos Tiboldi; Johannes Führer; Wolfgang Schaubmayr; Eva Hunyadi-Gulyas; Marie Louise Zach; Beatrix Hochreiter; Andreas Spittler; Roman Ullrich; Klaus Markstaller; Friedrich Altmann; Klaus Ulrich Klein; Verena Tretter Journal: Antioxidants (Basel) Date: 2021-12-04